Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gale

Showing results (341-350 of 361) with videos related to

Pageof 37
Sort By:
Science Translational Medicine|November 5, 2010
Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 diseaseForbes D Porter, David E Scherrer, Michael H Lanier, et al.
Immunohorizons|April 28, 2021
Indole-3-Carbinol-Dependent Aryl Hydrocarbon Receptor Signaling Attenuates the Inflammatory Response in Experimental Necrotizing EnterocolitisLila S Nolan, Belgacem Mihi, Pranjal Agrawal, et al.
JCI Insight|March 7, 2023
Microfluidic device facilitates in vitro modeling of human neonatal necrotizing enterocolitis-on-a-chipWyatt E Lanik, Cliff J Luke, Lila S Nolan, et al.
Cell Reports. Medicine|July 1, 2021
Interleukin-22 signaling attenuates necrotizing enterocolitis by promoting epithelial cell regenerationBelgacem Mihi, Qingqing Gong, Lila S Nolan, et al.
The New England Journal of Medicine|January 21, 2016
Assessment of Minimal Residual Disease in Standard-Risk AMLAdam Ivey, Robert K Hills, Michael A Simpson, et al.
Science Translational Medicine|May 6, 2016
Development of a bile acid-based newborn screen for Niemann-Pick disease type CXuntian Jiang, Rohini Sidhu, Laurel Mydock-McGrane, et al.
Glycobiology|March 10, 2011
G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunctionBu'hussain Hayee, Aristotelis Antonopoulos, Emma J Murphy, et al.
Blood|March 26, 2015
Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemiaAndrea Kühnl, Peter J M Valk, Mathijs A Sanders, et al.
Blood|March 9, 2017
Activation of the <i>LMO2</i> oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemiaSunniyat Rahman, Michael Magnussen, Theresa E León, et al.
Blood|June 5, 2009
WT1 mutations in T-ALLValeria Tosello, Marc R Mansour, Kelly Barnes, et al.
Pageof 37

Showing results (341-350 of 361) with videos related to

Sort By:
Pageof 37
Science Translational Medicine|November 5, 2010
Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 diseaseForbes D Porter, David E Scherrer, Michael H Lanier, et al.
Immunohorizons|April 28, 2021
Indole-3-Carbinol-Dependent Aryl Hydrocarbon Receptor Signaling Attenuates the Inflammatory Response in Experimental Necrotizing EnterocolitisLila S Nolan, Belgacem Mihi, Pranjal Agrawal, et al.
JCI Insight|March 7, 2023
Microfluidic device facilitates in vitro modeling of human neonatal necrotizing enterocolitis-on-a-chipWyatt E Lanik, Cliff J Luke, Lila S Nolan, et al.
Cell Reports. Medicine|July 1, 2021
Interleukin-22 signaling attenuates necrotizing enterocolitis by promoting epithelial cell regenerationBelgacem Mihi, Qingqing Gong, Lila S Nolan, et al.
The New England Journal of Medicine|January 21, 2016
Assessment of Minimal Residual Disease in Standard-Risk AMLAdam Ivey, Robert K Hills, Michael A Simpson, et al.
Science Translational Medicine|May 6, 2016
Development of a bile acid-based newborn screen for Niemann-Pick disease type CXuntian Jiang, Rohini Sidhu, Laurel Mydock-McGrane, et al.
Glycobiology|March 10, 2011
G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunctionBu'hussain Hayee, Aristotelis Antonopoulos, Emma J Murphy, et al.
Blood|March 26, 2015
Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemiaAndrea Kühnl, Peter J M Valk, Mathijs A Sanders, et al.
Blood|March 9, 2017
Activation of the <i>LMO2</i> oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemiaSunniyat Rahman, Michael Magnussen, Theresa E León, et al.
Blood|June 5, 2009
WT1 mutations in T-ALLValeria Tosello, Marc R Mansour, Kelly Barnes, et al.
Pageof 37